There is a large variation in hospital infection rates across the UK, with the worst performers having more than 5 times the number of cases than the best performing hospitals.
As part of their ongoing effort to combat HCAIs, Royal Manchester Children’s Hospital (RMCH) recently added the Surfacide Helios Ultraviolet C (UV-C) Disinfection System to its cleaning protocol. The Helios system is a triple-emitter UV-C hard surface disinfection system that eradicates multi-drug resistant organisms in the patient environment.
RMCH is the very first hospital within the NHS and the UK turning to UV-C technology as a complement to traditional cleaning methods. The hospital will be deploying four UV-C disinfection systems (12 emitters) throughout the hospital to protect patients and staff. This UV-C system uses three light emitting towers to safely and effectively disinfect all areas of a hospital room including tough to reach areas like bathrooms.
RMCH conducted an independent pilot study using the UV-C disinfection system in the hospital’s oncology/hematology unit. The eight-month independent study compared standard cleaning protocols alone to those including Surfacide Helios UV-C Disinfection. The result was an 83.7 percent decrease in contaminated sites and a 43 percent decrease in HAIs when the Helios system was introduced into the patient environment along with standard cleaning procedures. The Helios system was effective at reducing and eliminating a variety of drug-resistant microorganisms and has been shown to eradicate multi-drug resistant organisms, including C.Diff, MRSA, VRE, CRE and Acinetobacter.
